Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.

Show simple item record

dc.contributor.author Mugisho, Odunayo O
dc.contributor.author Rupenthal, Ilva D
dc.contributor.author Squirrell, David M
dc.contributor.author Bould, Sarah J
dc.contributor.author Danesh-Meyer, Helen V
dc.contributor.author Zhang, Jie
dc.contributor.author Green, Colin R
dc.contributor.author Acosta, Monica L
dc.contributor.editor Lewin, Alfred S
dc.coverage.spatial United States
dc.date.accessioned 2023-03-09T22:23:15Z
dc.date.available 2023-03-09T22:23:15Z
dc.date.issued 2018-01
dc.identifier.citation (2018). PLoS One, 13(8), e0202156-.
dc.identifier.issn 1932-6203
dc.identifier.uri https://hdl.handle.net/2292/63266
dc.description.abstract Diabetic retinopathy is a vascular disease of the retina characterised by hyperglycaemic and inflammatory processes. Most animal models of diabetic retinopathy are hyperglycaemia-only models that do not account for the significant role that inflammation plays in the development of the disease. In the present study, we present data on the establishment of a new animal model of diabetic retinopathy that incorporates both hyperglycaemia and inflammation. We hypothesized that inflammation may trigger and worsen the development of diabetic retinopathy in a hyperglycaemic environment. Pro-inflammatory cytokines, IL-1β and TNF-α, were therefore injected into the vitreous of non-obese diabetic (NOD) mice. CD1 mice were used as same genetic background controls. Fundus and optical coherence tomography images were obtained before (day 0) as well as on days 2 and 7 after intravitreal cytokine injection to assess vessel dilation and beading, retinal and vitreous hyper-reflective foci and retinal thickness. Astrogliosis and microgliosis were assessed using immunohistochemistry. Results showed that intravitreal cytokines induced vessel dilation, beading, severe vitreous hyper-reflective foci, retinal oedema, increased astrogliosis and microglia upregulation in diabetic NOD mice. Intravitreal injection of inflammatory cytokines into the eyes of diabetic mice therefore appears to provide a new model of diabetic retinopathy that could be used for the study of disease progression and treatment strategies.
dc.format.medium Electronic-eCollection
dc.language eng
dc.publisher Public Library of Science (PLoS)
dc.relation.ispartofseries PloS one
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject Animals
dc.subject Mice, Inbred NOD
dc.subject Mice
dc.subject Diabetic Retinopathy
dc.subject Diabetes Mellitus, Experimental
dc.subject Disease Models, Animal
dc.subject Blood Glucose
dc.subject Inflammation Mediators
dc.subject Cytokines
dc.subject Tomography, Optical Coherence
dc.subject Immunohistochemistry
dc.subject Severity of Illness Index
dc.subject Models, Biological
dc.subject Female
dc.subject Intravitreal Injections
dc.subject Biomarkers
dc.subject Eye Disease and Disorders of Vision
dc.subject Diabetes
dc.subject 2.1 Biological and endogenous factors
dc.subject 2 Aetiology
dc.subject Eye
dc.subject Metabolic and endocrine
dc.subject Science & Technology
dc.subject Multidisciplinary Sciences
dc.subject Science & Technology - Other Topics
dc.subject BLOOD-RETINAL BARRIER
dc.subject MACULAR-EDEMA
dc.subject HYPERREFLECTIVE FOCI
dc.subject MOUSE MODEL
dc.subject NOD MICE
dc.subject CELLS
dc.subject DEATH
dc.subject PATHOPHYSIOLOGY
dc.subject HYPERGLYCEMIA
dc.subject PERSPECTIVES
dc.subject 1103 Clinical Sciences
dc.subject 1113 Opthalmology and Optometry
dc.subject Biomedical
dc.subject Clinical Medicine and Science
dc.title Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.
dc.type Journal Article
dc.identifier.doi 10.1371/journal.pone.0202156
pubs.issue 8
pubs.begin-page e0202156
pubs.volume 13
dc.date.updated 2023-02-18T09:05:57Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 30133488 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/30133488
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Research Support, Non-U.S. Gov't
pubs.subtype research-article
pubs.subtype Journal Article
pubs.elements-id 752375
pubs.org-id Medical and Health Sciences
pubs.org-id Science
pubs.org-id Science Research
pubs.org-id School of Medicine
pubs.org-id Ophthalmology Department
pubs.org-id Maurice Wilkins Centre (2010-2014)
pubs.org-id Optometry and Vision Science
dc.identifier.eissn 1932-6203
dc.identifier.pii PONE-D-18-16252
pubs.number ARTN e0202156
pubs.record-created-at-source-date 2023-02-18
pubs.online-publication-date 2018-08-22


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics